Enigma Supplies POC Chlamydia Dx for UK Screening Program

genomeweb
360dx

Enigma Supplies POC Chlamydia Dx for UK Screening Program

Nov 09, 2007

NEW YORK (GenomeWeb News) — Enigma Diagnostics said today it has developed a DNA assay for the UK healthcare system to screen for Chlamydia trachomatis, the most common treatable sexually transmitted disease in that country.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Myriad Genetics Fiscal Q4 Revenues Up 1 Percent
European Working Group Develops System to Classify Tumor Genomic Alterations
Bionano Genomics Raises $20.6M in IPO, Starts Trading on Nasdaq
FDA Approves Expanded Use of Agilent Assay as Keytruda CDx for Urothelial Cancer
Gene Editing Firm Recombinetics Closes $34M Series A Round
PerkinElmer Adds DNA Quality Assessment Analyzer to Agena Nucleic Acid Detection System

The Scan

All So Similar

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A Very Long Time Ago Indeed

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

This Week in PNAS

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Genetic Condition to Drug Inspiration

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.

Main menu